Tackling the Candida Auris Threat with Innovative Enviro-Biotics® Technology
Candida Auris
The Emerging New Pandemic

The emergence of Candida Auris, a highly resistant and deadly fungus, demands urgent attention in the face of a growing global health concern. Candida Auris is not just any fungal infection; it’s a harbinger of a new era of superbugs that resist conventional cleaning agents and antifungal medications. First identified in Japan in 2009, this formidable pathogen has quickly spread across numerous countries, including the United States, posing a significant threat to healthcare and assisted living facilities.

Candida Auris’s ability to survive on surfaces for weeks, even after disinfection, exacerbates its threat. Its resistance to several antifungal drugs complicates treatment efforts, leading to severe, sometimes fatal infections, especially in those with weakened immune systems, where the mortality rate among these is approaching 50% !!. The pathogen’s resilience and capacity for rapid transmission through contact with contaminated surfaces/objects and person-to-person underscore the urgency of finding effective countermeasures.

Enter the revolutionary Enviro-Biotics® technology by Betterair, which presents a promising solution to the Candida Auris conundrum. This patented formula is dispersed continuously, 24/7, by automated devices, reaching every nook and cranny, including surfaces and objects that are hard to reach or too delicate for traditional disinfectants. Enviro-Biotics® operates on a simple yet powerful premise: it consumes the nutrients essential for Candida Auris’s survival, effectively starving and killing the fungus. Moreover, it establishes a protective layer of beneficial microflora, preventing the growth of harmful microbes.

Betterair Enviro-Biotics® effectiveness on surfaces is pivotal against Candida Auris because Candida is infectious by touching and not by inhalation. We have recently completed controlled environmental studies conducted in collaboration with Hayes Laboratory, an FDA/EPA complaint.
The study established a 100% reduction in Candida Auris contamination.
This study is added to the many others in which we applied Enviro-Biotics® against other microbes. We are very pleased with similar results that reinforced the efficacy of Enviro-Biotics® as a general solution, and probably the only one, to every type of harmful microbe, ensuring safer environments for all.

 

For more information about implementing Enviro-Biotics® in your facility, visit www.better-air.com or contact Betterair at contact@better-air.com or (833) 692-3883. Together, we can turn the tide against Candida Auris and pave the way for a healthier future.